Designates first full week of May of each year as "Tardive Dyskinesia Awareness Week" in NJ.
The designation of Tardive Dyskinesia Awareness Week is vital as it seeks to educate the public about the symptoms and effects of this condition. Research indicates that approximately 600,000 people in the U.S. suffer from TD, yet many remain undiagnosed, with significant numbers of individuals in New Jersey potentially affected. This resolution emphasizes the necessity of regular screenings for those on long-term antipsychotic treatments, which could significantly improve early intervention and treatment outcomes for patients suffering from TD.
SJR110 is a Senate Joint Resolution introduced in New Jersey, designating the first full week of May of each year as 'Tardive Dyskinesia Awareness Week'. This resolution aims to address the impacts of Tardive Dyskinesia (TD), a neurological disorder characterized by uncontrollable and repetitive movements often induced by dopamine receptor blocking agents (DRBAs), commonly used in treating various mental health conditions such as schizophrenia and bipolar disorder. The bill highlights the importance of awareness and early diagnosis, suggesting that timely monitoring and screening can lead to better management and treatment of the disorder.
While the bill seeks to raise awareness, there are underlying challenges regarding the stigma associated with TD and similar mental health conditions. People experiencing TD may face social and emotional barriers, complicating their willingness to seek help. Furthermore, the resolution underscores the need for increased resources to aid patients, caregivers, and healthcare providers, as the current lack of awareness contributes to misconceptions about TD and the people affected by it. The call for a designated week aims not only at improving public knowledge but also at fostering a supportive environment for discussions surrounding mental health issues and the importance of early intervention.